Navigation Links
Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices
Date:4/3/2009

PHILADELPHIA, April 3 /PRNewswire-USNewswire/ -- Hahnemann University Hospital's ventricular assist device program has earned the Gold Seal of Approval(TM) for health care quality. Ventricular assist devices (VAD) are mechanical pumps that allow damaged hearts to continue functioning while patients either await a heart transplant, or for destination therapy when transplant is not a viable option.

"Hahnemann sought accreditation for our VAD program because we wanted to demonstrate our commitment to our patients' safety and quality care," said George Amrom, M.D., chief medical officer of Hahnemann University Hospital. "Ventricular Assist Devices continue to become more sophisticated and allow our patients a treatment option that had not been available to them in the past."

To earn this distinction, a disease management program undergoes an extensive, unannounced, on-site evaluation by a team of Joint Commission reviewers every two years. The program is evaluated against Joint Commission standards through an assessment of a program's processes, the program's ability to evaluate and improve care within its own organization, and interviews with patients and staff.

"This certification means Hahnemann University Hospital does the right things and does them well for ventricular assist device patients," says Jean E. Range, M.S., R.N., C.P.H.Q., executive director, Disease-Specific Care Certification, Joint Commission.

The Joint Commission launched its Disease-Specific Care Certification program in 2002. It is the first program of its kind in the country to certify disease management programs. A list of programs certified by the Joint Commission is available at www.jointcommission.org.

About Hahnemann University Hospital

Hahnemann University Hospital is a 541-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments. The hospital performed one of the city's first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia's first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation's oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher's Hospital for Children. To learn more about Hahnemann, visit www.hahnemannhospital.com.


'/>"/>
SOURCE Hahnemann University Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hahnemann University Hospital and St. Christophers Hospital for Children Receive Prestigious Tenet Circle of Excellence Award
2. Hahnemann University Hospital and St. Christophers Hospital for Children Extend Current Agreement With Independence Blue Cross
3. Hospital Workers Ratify Contract With Hahnemann
4. Hahnemann University Hospital Receives Approval From The Commission on Cancer
5. University of Iowa professor identifies new eating disorder
6. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
7. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
8. Tulane University to receive $14M for international HIV/AIDS program
9. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
10. Boston University School of Medicine researcher recipient of Memory Ride Grant
11. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... Pa. and KALAMAZOO, Mich. , Sept. 18, ... , and OptiMed Specialty Pharmacy of ... to offer a strategic hub service that expedites and ... sought-after personal spirometer, Spiro PD 2.0, and wellness management ... spirometer is a medical device used to measure lung ...
Breaking Medicine Technology: